Literature DB >> 20808979

Airway remodelling in asthma: from benchside to clinical practice.

Céline Bergeron1, Meri K Tulic, Qutayba Hamid.   

Abstract

Airway remodelling refers to the structural changes that occur in both large and small airways relevant to miscellaneous diseases including asthma. In asthma, airway structural changes include subepithelial fibrosis, increased smooth muscle mass, gland enlargement, neovascularization and epithelial alterations. Although controversial, airway remodelling is commonly attributed to an underlying chronic inflammatory process. These remodelling changes contribute to thickening of airway walls and, consequently, lead to airway narrowing, bronchial hyper-responsiveness, airway edema and mucous hypersecretion. Airway remodelling is associated with poor clinical outcomes among asthmatic patients. Early diagnosis and prevention of airway remodelling has the potential to decrease disease severity, improve control and prevent disease expression. The relationship between structural changes and clinical and functional abnormalities clearly deserves further investigation. The present review briefly describes the characteristic features of airway remodelling observed in asthma, its clinical consequences and relevance for physicians, and its modulation by therapeutic approaches used in the treatment of asthmatic patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20808979      PMCID: PMC2933777          DOI: 10.1155/2010/318029

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  130 in total

Review 1.  Airway remodeling in asthma.

Authors:  J A Elias; Z Zhu; G Chupp; R J Homer
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  Enhanced proteoglycan deposition in the airway wall of atopic asthmatics.

Authors:  J Huang; R Olivenstein; R Taha; Q Hamid; M Ludwig
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

3.  Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey.

Authors:  B Leynaert; J Bousquet; C Neukirch; R Liard; F Neukirch
Journal:  J Allergy Clin Immunol       Date:  1999-08       Impact factor: 10.793

4.  The shedding of the mucosa of the bronchial tree in asthma.

Authors:  B NAYLOR
Journal:  Thorax       Date:  1962-03       Impact factor: 9.139

5.  Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma.

Authors:  M Hoshino; M Takahashi; Y Takai; J Sim
Journal:  J Allergy Clin Immunol       Date:  1999-08       Impact factor: 10.793

6.  Regulation of TH1- and TH2-type cytokine expression and action in atopic asthmatic sensitized airway smooth muscle.

Authors:  H Hakonarson; N Maskeri; C Carter; M M Grunstein
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

7.  Cellular infiltration and cytokine mRNA expression in perennial allergic rhinitis.

Authors:  E M Varga; M R Jacobson; S J Till; K Masuyama; F O'Brien; S Rak; V Lund; G K Scadding; Q A Hamid; S R Durham
Journal:  Allergy       Date:  1999-04       Impact factor: 13.146

8.  Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling.

Authors:  C Laprise; M Laviolette; M Boutet; L P Boulet
Journal:  Eur Respir J       Date:  1999-07       Impact factor: 16.671

9.  Inhaled beclomethasone improves the course of asthma and COPD.

Authors:  E Dompeling; C P van Schayck; J Molema; H Folgering; P M van Grunsven; C van Weel
Journal:  Eur Respir J       Date:  1992-09       Impact factor: 16.671

10.  Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness.

Authors:  W T Watson; A B Becker; F E Simons
Journal:  J Allergy Clin Immunol       Date:  1993-01       Impact factor: 10.793

View more
  83 in total

1.  Glycomacropeptide administration attenuates airway inflammation and remodeling associated to allergic asthma in rat.

Authors:  Nuria Renata Roldán; Mariela Jiménez; Daniel Cervantes-García; Estefanía Marín; Eva Salinas
Journal:  Inflamm Res       Date:  2016-01-11       Impact factor: 4.575

Review 2.  Mast Cell-Mediated Orchestration of the Immune Responses in Human Allergic Asthma: Current Insights.

Authors:  Daniel Elieh Ali Komi; Leif Bjermer
Journal:  Clin Rev Allergy Immunol       Date:  2019-04       Impact factor: 8.667

Review 3.  Mechanisms how mucosal innate immunity affects progression of allergic airway disease.

Authors:  Allan R Brasier
Journal:  Expert Rev Respir Med       Date:  2019-02-13       Impact factor: 3.772

4.  TRPC1 intensifies house dust mite-induced airway remodeling by facilitating epithelial-to-mesenchymal transition and STAT3/NF-κB signaling.

Authors:  Qinqin Pu; Yuanyu Zhao; Yuyang Sun; Ting Huang; Ping Lin; Chuanmin Zhou; Shugang Qin; Brij B Singh; Min Wu
Journal:  FASEB J       Date:  2018-08-01       Impact factor: 5.191

5.  Mabs for treating asthma: omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab.

Authors:  Erminia Ridolo; Francesco Pucciarini; Maria Cristina Nizi; Eleni Makri; Paola Kihlgren; Lorenzo Panella; Cristoforo Incorvaia
Journal:  Hum Vaccin Immunother       Date:  2020-05-13       Impact factor: 3.452

Review 6.  ORAI channels in cellular remodeling of cardiorespiratory disease.

Authors:  Martin Johnson; Mohamed Trebak
Journal:  Cell Calcium       Date:  2019-02-08       Impact factor: 6.817

7.  γ-Tocotrienol Inhibits TGF-β1-Induced Contractile Phenotype Expression of Human Airway Smooth Muscle Cells.

Authors:  Takehito Fukushima; Akira Yamasaki; Tomoya Harada; Hiroki Chikumi; Masanari Watanabe; Ryota Okazaki; Miki Takata; Yasuyuki Hasegawa; Jun Kurai; Masaaki Yanai; Akihiro Yamamoto; Yuriko Sueda; Andrew J Halayko; Eiji Shimizu
Journal:  Yonago Acta Med       Date:  2017-03-09       Impact factor: 1.641

8.  AVE 0991, a non-peptide mimic of angiotensin-(1-7) effects, attenuates pulmonary remodelling in a model of chronic asthma.

Authors:  M G Rodrigues-Machado; G S Magalhães; J A Cardoso; L M Kangussu; A Murari; M V Caliari; M L Oliveira; D C Cara; M L M Noviello; F D Marques; J M Pereira; R Q Lautner; R A S Santos; M J Campagnole-Santos
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

9.  Mucosal bromodomain-containing protein 4 mediates aeroallergen-induced inflammation and remodeling.

Authors:  Bing Tian; Koa Hosoki; Zhiqing Liu; Jun Yang; Yingxin Zhao; Hong Sun; Jia Zhou; Erik Rytting; Lata Kaphalia; William J Calhoun; Sanjiv Sur; Allan R Brasier
Journal:  J Allergy Clin Immunol       Date:  2018-10-13       Impact factor: 10.793

10.  Steroid-independent upregulation of matrix metalloproteinase 9 in chronic rhinosinusitis patients with radiographic evidence of osteitis.

Authors:  Kara Y Detwiller; Timothy L Smith; Jess C Mace; Dennis R Trune; Nathan B Sautter
Journal:  Int Forum Allergy Rhinol       Date:  2013-02-08       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.